PubMed

Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment.

Bolz M, Michels S, Geitzenauer W, Prager F, Schmidt-Erfurth U.

Br J Ophthalmol. 2007 Jun;91(6):785-9. Epub 2006 Oct 18.PMID: 17050580 [PubMed - indexed for MEDLINE]Related articles

One-year results of combined photodynamic therapy and intravitreal bevacizumab injection for retinal pigment epithelial detachment secondary to age-related macular degeneration.

Shima C, Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Tano Y.

Graefes Arch Clin Exp Ophthalmol. 2009 Jul;247(7):899-906. Epub 2009 Mar 24.PMID: 19308441 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.

Ladas ID, Kotsolis AI, Papakostas TD, Rouvas AA, Karagiannis DA, Vergados I.

Retina. 2007 Sep;27(7):891-6.PMID: 17891013 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

Retina. 2007 Apr-May;27(4):432-8.PMID: 17420694 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ.

Ophthalmology. 2006 Mar;113(3):363-372.e5. Epub 2006 Feb 3.PMID: 16458968 [PubMed - indexed for MEDLINE]Related articles

Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study.

Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, Venkatraman AS.

Ophthalmology. 2005 Jun;112(6):1035-47.PMID: 15936441 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.

Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A.

Retina. 2006 Nov-Dec;26(9):999-1005.PMID: 17151486 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.

Emerson MV, Lauer AK, Flaxel CJ, Wilson DJ, Francis PJ, Stout JT, Emerson GG, Schlesinger TK, Nolte SK, Klein ML.

Retina. 2007 Apr-May;27(4):439-44.PMID: 17420695 [PubMed - indexed for MEDLINE]Related articles

Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.

Chan CK, Meyer CH, Gross JG, Abraham P, Nuthi AS, Kokame GT, Lin SG, Rauser ME, Kaiser PK.

Retina. 2007 Jun;27(5):541-51.PMID: 17558314 [PubMed - indexed for MEDLINE]Related articles

[Early effects of systemic and intravitreal bevacizumab (avastin) therapy for neovascular age-related macular degeneration]

Geitzenauer W, Michels S, Prager F, Kornek G, Vormittag L, Rosenfeld P, Schmidt-Erfurth U.

Klin Monbl Augenheilkd. 2006 Oct;223(10):822-7. German. PMID: 17063425 [PubMed - indexed for MEDLINE]Related articles

Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study.

Moshfeghi AA, Rosenfeld PJ, Puliafito CA, Michels S, Marcus EN, Lenchus JD, Venkatraman AS.

Ophthalmology. 2006 Nov;113(11):2002.e1-12. Epub 2006 Oct 5.PMID: 17027972 [PubMed - indexed for MEDLINE]Related articles

Treatment of choroidal neovascularization using intravitreal bevacizumab.

Pedersen R, Soliman W, Lund-Andersen H, Larsen M.

Acta Ophthalmol Scand. 2007 Aug;85(5):526-33. Epub 2007 May 18.PMID: 17511757 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration.

Bashshur ZF, Bazarbachi A, Schakal A, Haddad ZA, El Haibi CP, Noureddin BN.

Am J Ophthalmol. 2006 Jul;142(1):1-9.PMID: 16815245 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage.

Stifter E, Michels S, Prager F, Georgopoulos M, Polak K, Hirn C, Schmidt-Erfurth U.

Am J Ophthalmol. 2007 Dec;144(6):886-892. Epub 2007 Oct 4.PMID: 17916314 [PubMed - indexed for MEDLINE]Related articles

Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.

Ahmadieh H, Taei R, Soheilian M, Riazi-Esfahani M, Karkhaneh R, Lashay A, Azarmina M, Dehghan MH, Moradian S.

BMC Ophthalmol. 2007 Jun 7;7:10.PMID: 17555600 [PubMed - indexed for MEDLINE]Related articlesFree article

Photodynamic therapy with verteporfin for age-related macular degeneration or polypoidal choroidal vasculopathy: comparison of the presence of serous retinal pigment epithelial detachment.

Saito M, Iida T, Nagayama D.

Br J Ophthalmol. 2008 Dec;92(12):1642-7. Epub 2008 Sep 9.PMID: 18782798 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.

Weigert G, Michels S, Sacu S, Varga A, Prager F, Geitzenauer W, Schmidt-Erfurth U.

Br J Ophthalmol. 2008 Mar;92(3):356-60.PMID: 18303156 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration.

Aisenbrey S, Ziemssen F, Völker M, Gelisken F, Szurman P, Jaissle G, Grisanti S, Bartz-Schmidt KU.

Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):941-8. Epub 2006 Dec 21.PMID: 17186262 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for refractory pigment epithelial detachment with occult choroidal neovascularization in age-related macular degeneration.

Chen E, Kaiser RS, Vander JF.

Retina. 2007 Apr-May;27(4):445-50.PMID: 17420696 [PubMed - indexed for MEDLINE]Related articles

Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.

Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia MJ, Costa RA; Pan-American Collaborative Retina Study Group.

Retina. 2008 Nov-Dec;28(10):1387-94.PMID: 18827735 [PubMed - indexed for MEDLINE]Related articles